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Abstract
Purpose: Dry eye syndrome is a multifactorial chronic disabling disease mainly caused by the functional disruptions in the
lacrimal gland. The treatment involves palliation like ocular surface lubrication and rehydration. Cell therapy involving
replacement of the gland is a promising alternative for providing long-term relief to patients. This study aimed to establish
functionally competent lacrimal gland cultures in–vitro and explore the presence of stem cells in the native gland and the
established in-vitro cultures.
Methods: Fresh human lacrimal gland from patients undergoing exenteration was harvested for cultures after IRB approval.
The freshly isolated cells were evaluated by flow cytometry for expression of stem cell markers ABCG2, high ALDH1 levels
and c-kit. Cultures were established on Matrigel, collagen and HAM and the cultured cells evaluated for the presence of
stem cell markers and differentiating markers of epithelial (E-cadherin, EpCAM), mesenchymal (Vimentin, CD90) and
myofibroblastic (a-SMA, S-100) origin by flow cytometry and immunocytochemistry. The conditioned media was tested for
secretory proteins (scIgA, lactoferrin, lysozyme) post carbachol (100 mM) stimulation by ELISA.
Results: Native human lacrimal gland expressed ABCG2 (mean6SEM: 3.160.61%), high ALDH1 (3.861.26%) and c-kit
(6.762.0%). Lacrimal gland cultures formed a monolayer, in order of preference on Matrigel, collagen and HAM within 15–20
days, containing a heterogeneous population of stem-like and differentiated cells. The epithelial cells formed ‘spherules’
with duct like connections, suggestive of ductal origin. The levels of scIgA (47.43 to 61.56 ng/ml), lysozyme (24.36 to
144.74 ng/ml) and lactoferrin (32.45 to 40.31 ng/ml) in the conditioned media were significantly higher than the negative
controls (p,0.05 for all comparisons).
Conclusion: The study reports the novel finding of establishing functionally competent human lacrimal gland cultures in-
vitro. It also provides preliminary data on the presence of stem cells and duct-like cells in the fresh and in-vitro cultured
human lacrimal gland. These significant findings could pave way for cell therapy in future.
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Introduction
The stability and integrity of the ocular surface depends greatly
on the stability of the tear film that covers the anterior surface of
the eye. The tear film has three basic layers - the outer thin lipid
layer secreted by the meibomian glands, the middle bulk of
aqueous layer secreted by the lacrimal gland and the inner
mucinous layer secreted by the conjunctival goblet cells.
Collectively, these three layers of the tear film perform a number
of important physiological functions [1]: it keeps the cornea wet
allowing gaseous exchange between the environment and the
epithelium, it provides a clear and regular optical surface for sharp
image focusing on the retina, it clears the debris from the ocular
surface and protects it from microbial invasion. Deficiency and loss
of tear film integrity, atrophy of the lacrimal gland or apoptosis
of the secretory epithelial cells due to hormonal imbalance,
environmental changes, autoimmune pathologies or radiotherapy
induces pathological changes in the gland and leads to a chronic
disabling condition called the dry eye syndrome (DES).
The 2007 International Dry Eye Workshop (DEWS) report
estimated the global prevalence of DES to be between 5% to over
35% at various ages (21 yr to .65 yr) [2]. Clinically, chronic dry
eye causes a significant drop in contrast sensitivity and visual
acuity leading to degraded performance in routine vision related
activities like driving, reading [3,4]. The signs and symptoms
include ocular dryness, grittiness, burning and foreign body
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Over time the loss of tear film integrity induces corneal epithelial
irregularities and epithelial defects [6] with higher risks of
secondary infection [7]. The pathological features of dry eye
include lymphocytic infiltration of the lacrimal gland [8],
reversible squamous metaplasia [8], apoptosis of secretory
epithelial cells, loss of a-smooth muscle actin and tenascin C
expression in the myoepithelial cells indicating loss of function [9].
Together these contribute to reduced tear secretion and result in
the signs and symptoms of dry eye. Biochemically, there is
hyperosmolarity of the tear film either due to reduced tear
production or excessive tear evaporation from the ocular surface
causing a reduction in tear film thickness from (mean 6 SD)
6.062.4 mm in normal subjects to about 2.061.5 mm in dry eye
patients [10].
Current treatment for dry eye primarily involves the use of
lubricating eye drops or pharmacological stimulation of tears
secretion [7,11]. However, these treatment modalities provide only
temporary relief and have the inherent drawbacks of associated
side effects and suboptimal results due to loss of secretory function
of the gland [7]. In severe cases, especially in those with
permanent damage to lacrimal gland, there arises a need to
replace the gland and restore its functionality using appropriate
cell therapy. To achieve this long-term goal it is important to
establish and evaluate functionally competent in-vitro cell culture
system.
Animal studies [12,13,14] have successfully demonstrated the
establishment of in-vitro lacrimal gland cell cultures, using different
media and scaffolds [12,15]. However, work on human in-vitro
lacrimal gland culture is scarce [16]; possibly due to paucity of
fresh tissues and the fragile nature of these cultures. Recent studies
have shown the presence of stem cells in exocrine glands like
salivary [17], pancreas [18,19], prostate [20] and breast [21,22].
These reports have prompted investigations on the potentials of
using in-vitro cultured cells for regenerative therapy with promising
outcomes. However in the case of lacrimal gland, there is only
preliminary report on the presence of stem cells in the mouse
lacrimal gland [23,24] and, to the best of our knowledge, none
investigating the presence of stem cells in human lacrimal gland.
With this background in mind, the present study had two
important aims: 1) to establish functionally competent human
lacrimal gland cultures in-vitro and 2) investigate the presence of
stem cells in the native tissue as well as in the established in-vitro
cultures.
Materials and Methods
Chemicals
HepatoSTIM culture media (BD biosciences, San Jose, CA,
USA), Dulbecco’s Modified Eagle’s Medium (DMEM) - Ham’s F12
(Sigma Aldrich, St Louis, MO,USA) Fetal calf serum (FCS)
(Hyclone), bovine serum albumin (BSA) (Sigma Aldrich, St Louis,
Mo, USA) penicillin, streptomycin, gentamysin and amphotericin
B, epidermal growth factor (Sigma Aldrich, St Louis,MO, USA), L-
glutamine (2 mM) (Sigma Aldrich, St Louis, MO, USA), MatrigelH
basement matrix (BD Biosciences, San Jose, CA, USA), collagen I
gel (Sigma Aldrich, St Louis, MO, USA), collagnease (Invitrogen,
Carlsbad, CA, USA), hyaluronidase (Invitrogen, Carlsbad,
CA,USA), Hank’s Balanced Salt Solution (HBBS), TRIzol
(Invitrogen, Carlsbad, CA,USA), Superscript first strand synthesis
system for RT-PCR (Invitrogen, Carlsbad, CA, USA) anti- E-
cadherin antibody (Chemicon, Temecula, CA, USA), anti-ABCG2
(BD Biosciences, San Jose, CA, USA), anti c-kit (Millipore,
Temecula, CA; Dako, Glostrup, Denmark), anti-p63 (Dako,
Glostrup, Denmark) anti-CD133 (Miltenyi Biotech), anti-EpCAM
(BD Biosciences, San Jose, CA, USA) anti- lysozyme (Abcam), anti-
lactoferrin (Millipore, Temecula, CA, USA), anti-scIgA (Dako,
Glostrup, Denmark), anti- GFAP (Dako, Glostrup, Denmark), anti-
S100 protein (Dako, Glostrup, Denmark) anti CD90 (eBioscience),
anti-vimentin (Dako, Glostrup, Denmark), anti-CK3/12 (Dako,
Glostrup, Denmark), Aldefluor Assay Kit (Stem Cell Technology,
Durham, NC,USA), Fluroscein Isothiocynate (Invitrogen, Carls-
bad, CA,USA), Alexa Fluor 488 (Invitrogen, Carlsbad, CA, USA),
Phycoerytherin (eBioscience), human lactoferrin ELISA kit (Assay-
Pro, MO, USA), human lysozyme ELISA kit (AssayPro, MO,
USA), human IgA ELISA kit (Immunology Consultants Laborato-
ry, Inc, Newberg, OR, USA).
Human Tissue Source
The study was conducted at the L V Prasad Eye Institute
(LVPEI), Hyderabad. The use of human tissue was approved by
the Institutional Review Board (IRB) and is in accordance with the
tenets of the Declaration of Helsinki. Fresh human lacrimal gland
was harvested, after obtaining written informed consent, from
patients undergoing exenteration surgery. The lacrimal gland was
immunohistochemically evaluated to be free from any underlying
pathology. The fresh gland was collected in FCS rich DMEM-
Ham’s F-12 media supplemented with antibiotics and transported
to the lab where it was immediately taken for processing.
Preparation of human amniotic membrane
The use of human amniotic membrane has been approved by
the IRB of LVPEI, Hyderabad. Human amniotic membrane
(HAM) was prepared according to the protocol published by Kim
et.al [25] Following written informed consent, human placenta was
obtained at the time of normal cesarean delivery at the Fernandez
Hospital, Hyderabad. The placenta was transported to the
Ramayamma International Eye Bank (LVPEI, Hyderabad) and
processed under sterile conditions using saline/ringer lactate
solution. The amnion was separated from the chorion by peeling
and attached onto sterile nitrocellulose paper and cut into
2.565.0 cm pieces. The amniotic membrane pieces were stored
in glass vials containing DMEM and stored at 270uC. Just prior to
use, it was thawed at 37uC for 30 minutes. HAM was de-
epithelized by incubating with 0.25% trypsin–EDTA for 30 min-
utes at 37uC followed by thorough washing with PBS to remove
the epithelial layer [26].
Establishment of primary culture. Fresh lacrimal gland
was washed with HBBS to remove red blood cells. The gland was
chopped into small bits using a scalpel blade (#21). The tissue
mince was then incubated with the enzyme cocktail of collagenase
(130 units per ml) and hyaluronidase (300 units per ml) for
90 minutes at 37uC with intermittent shaking. At the end of the
incubation period, the suspension was filtered through a 75 mm
cell sieve and the cell pellet obtained by centrifugation at
1500 rpm for 20 min. The cells were seeded on uncoated tissue
culture dishes in DMEM-Ham’s F12 culture media supplemented
with 10% FCS and antibiotics.
The heterogeneous mix of isolated cells was separated based on
their preferential adhesion to uncoated tissue culture dishes. The
fibroblasts attached preferentially to the uncoated tissue culture
dishes and the epithelial clumps, still in suspension at the end of
around 2 hours, were aspirated and plated on Matrigel
TM,
collagen I coated dishes and on denuded HAM. The media used
for the culture of fibroblasts was DMEM- Ham’s F-12 supple-
mented with 2 mM L-glutamine, antibiotics and 10% FCS. For
the culture of lacrimal acinar cells, HepatoSTIM
TM culture media
was used. HepatoSTIMH is a commercially available fully defined,
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[27] and contains supplements like dexamethasone, insulin-
transferrin-selinium (ITS) and EGF. The media was further
supplemented with 2 mM L-glutamine, penicillin, streptomycin,
5 ng/ml EGF and 10% FCS for the first three days. At the end of
the three days/at first media change, FCS was completely
eliminated from the media and the concentration of EGF
increased to 50 ng/ml.
Characterization of native lacrimal gland and in-vitro
lacrimal gland culture. The native lacrimal gland and 14–18
th
day in-vitro cultures of human lacrimal gland, growing as a monolayer
on Matrigel
TM were characterized by immunohistochemistry, immu-
nocytochemistry, flow cytometry, reverse-transcriptase polymerase
chain reaction (RT-PCR) and enzyme linked Immunosorbent assay
(ELISA).
Immunohistochemistry
Expression of markers like Pan-cytokeratin (AE1/AE3), vimen-
tin, p63, /-SMA, GFAP, S-100, lysozyme and c-kit protein was
evaluated in formalin fixed, paraffin embedded sections of fresh
lacrimal gland. The sections were also stained with hematoxylin &
eosin (H&E) as well as periodic acid schiff’s (PAS) to visualize the
histology of the gland.
The fresh gland was fixed with 10% fresh formalin and
embedded in paraffin. Thin 3 mm sections were taken on silane
coated glass slides and used for immunostaining. Briefly, the
paraffin embedded sections were deparaffinized at around 70uC
and then in xylene series. The sections were rehydrated in alcohol
series and then in distilled water followed by 1X PBS. The
endogenous peroxidase activity was blocked using methanol and
hydrogen peroxide and the antigen retrieval done using Tris-
EDTA buffer (pH 9). After appropriate washings with PBS and
blocking with 2.5% BSA, the sections were incubated with the
primary antibody in a moist chamber for 2 hours at room
temperature followed by secondary antibody (polymer HRP)
incubation for 30 minutes at room temperature. DAB substrate
was added to the section to allow color development for
10 minutes. This was followed by counterstaining with hematox-
ylene and then mounting in DPX. The sections were visualized
under a light microscope.
The source of the antibodies used and the appropriate dilutions
are summarized in Table 1.
Immunocytochemistry
The in-vitro cultures of lacrimal gland at day 14–18 were
immunostained for epithelial markers like cytokeratin 3/12, E-
cadherin, p63; myoepithelial markers like S100, GFAP; and
mesenchymal markers vimentin and CD 90. In addition, the cells
were also immunostained with ABCG2 and secretory protein
lysozyme. Briefly, the cells were fixed with 4% fresh paraformal-
dehyde (PFA) for 10 minutes, followed by permeabilization with
50% methanol for 20 minutes for intracellular markers. The cells
were then incubated with appropriate dilutions of the primary
antibody for 2 h at room temperature.
Secondary antibodies like Alexa Fluor 488, FITC and PE were
used against the respective immunoglobulins of the primary
antibody at 1:200 dilution. The incubation time was 45 min.
Nuclear staining was done with 4,6-diamidino-2-phenylindole
(DAPI) or propidium iodide (PI). The coverslips were mounted in
50% glycerol and the images acquired using Carl Zeiss Laser
Scanning Microscope LSM 510.
The source of the antibodies used and the appropriate dilutions
are summarized in Table 2, 3 and 4.
Flow Cytometry
Lacrimal gland cells, freshly isolated from the gland as well as
14–18 days and 21–25 days post in-vitro culture, were evaluated by
flow cytometry to detect the number of cells positive for epithelial
markers like E-cadherin, EpCAM and mesenchymal markers like
CD90. Putative stem cell markers like ABCG2, c-kit were also
used to investigate the presence of stem cell compartment.
Expression of CD133, which has recently been recognized as a
stem cell marker/marker for glandular epithelium [28], was also
evaluated.
Cells were isolated from the human lacrimal gland by enzymatic
digestion as described previously in the study. Cells growing as
monolayers on Matrigel
TM were trypsinized using 0.25% trypsin-
EDTA (TE) and used for evaluation of marker expression by flow
cytometry.
Briefly, 1610
6 cells were fixed with 4% fresh PFA for
10 minutes, blocked with 5% BSA and incubated with appropriate
dilutions of primary antibody for 2 hours at room temperature.
The cell pellet was washed with PBS and then incubated with
1:200 dilutions of appropriate secondary antibodies for 45 min-
utes. At the end of this time period, the pellet was washed with
PBS, resuspended in 500 ml of FACS buffer and acquired on BD
FACS ARIA
TM Special Order System. Appropriate controls were
used for the experiment. A total of 20000 to 50000 events were
acquired for analysis. The analysis was done using BD FACS
DiVa
TM software.
The source of the antibodies used and the appropriate dilutions
are summarized in Table 2, 3 and 4.
Table 1. List of antibodies and dilutions used for
immunohistochemistry.
S. No. Antibody Dilution Company
1. p63 Neat Dako
2. /-SMA Neat Dako
3. GFAP Neat Dako
4. S-100 protein Neat Dako
5. Lysozyme 1:100 Abcam
6. c-kit 1:100 Dako
7. Pan-cytokeratin (AE1/AE3) 1:50 Dako
8. Vimentin 1:200 Dako
doi:10.1371/journal.pone.0029458.t001
Table 2. List of antibodies and dilutions used for
immunocytochemistry.
S. No. Antibody Dilution Company
1 E- cadherin 1:100 Millipore
2. Cytokeratin 3/12 1:100 Millipore
3. CD90 1:200 eBiosciences
4. Vimentin 1:100 Dako
5. GFAP Neat Dako
6. S-100 protein Neat Dako
7. Lysozyme 1:100 Abcam
doi:10.1371/journal.pone.0029458.t002
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ALDEFLUORH fluorescent reagent system (Stem Cell Tech-
nologies) provides a novel method for identification of stem and
progenitor cells based on their expression of enzyme aldehyde
dehydrogenase1 (ALDH). The fluorescent ALDEFLUORH re-
agent diffuses freely into the cells and acts as a non-toxic substrate
for ALDH. The fluorescent reaction product that accumulates in
the cells can be measured in the green channel of a standard flow
cytometer and it correlates directly to the ALDH activity in the
cell. With this assay, stem and progenitor cells are identified as
cells with higher expression of ALDH1.
For the assay, 1610
6 cells/ml (freshly isolated from the lacrimal
gland as well as post trypsinization from the cultured monolayer
on day 14–18 and day 21–25) were taken and divided into two
groups: control and test. To the control tube 5 ml of ALDH
inhibitor DEAB was added. 5 ml/ml of activated ALDEFLOURH
substrate was added to the test group and immediately half of the
cell suspension was transferred to the control tube. Both the test as
well as the control sample was incubated at 37uC for 30 to 60 min.
At the end of the incubation period the supernatant was removed
after centrifugation and the cells resuspended in 0.5 ml of
ALDEFLUORH Assay Buffer and the fluorescence measured in
the green channel of FACS ARIA
TM Special Order System.
Reverse- Transcriptase Polymerase Chain Reaction
Total RNA was extracted from the freshly isolated as well as
cultured cells using the TRIzolH reagent according to the
manufacturer’s instructions. The quality of the RNA isolated
was checked by visualization on agarose gel. 2 mg of RNA was
used for cDNA synthesis per 25 ml of the reaction volume using
the Superscript
TM First Strand Synthesis System for RT-PCR
according to the manufacturer’s instructions. The primer
sequences used for reverse transcriptase polymerase chain reaction
are summarized in Table 5.
PCR amplification was carried out using the Applied Biosystems
Veriti 96 well thermal cycler. The reaction was stopped at 35 PCR
cycles. The amplified products were visualized on agarose gel and
the product size estimated.
Measurement of secretory components
Free secretory products of lacrimal acinar cells like scIgA,
lactoferrin and lysozyme were detected in the culture supernatant
of day 6–7, day 14 and day 21 cultures according to the
manufacturer’s instructions. All the reagents used were supplied as
a part of the ELISA kit. A standard curve was generated for each
experiment performed.
Briefly, 50 ml of the standard protein or culture supernatant was
added to the wells of polypropylene U bottom ELISA plates and
incubated for 2 hours at room temperature. The plates were
washed at least five times with the wash buffer (supplied with the
kit) ensuring complete removal of the liquid at each step. 50 mlo f
biotinylated primary antibody (lysozyme/lactoferrin/scIgA) (1:100
dilution) was added to each of the sample-coated wells and
incubated for one hour at room temperature followed by thorough
washing with the wash buffer. 50 ml of streptavidine-peroxidase
conjugate was added to each well and incubated for 30 minutes.
At the end of the incubation period, the wells were washed
thoroughly and incubated with 50 ml/well of the chromogen
substrate for 10 minutes at room temperature. The reaction was
stopped by adding 50 ml of stop solution to each well and a color
change from blue to yellow is noted. The optical density (OD) was
then measured immediately at 450 nm on ELISA microplate
reader (BioRad iMark
TM Microplate Reader).
Statistical Analysis
Values are expressed as mean of triplicate readings 6 SEM
unless otherwise indicated. The statistical test used was two-way
ANOVA with post hoc Tukey test. Statistical package SPSS
Version 19 was used for analysis and graphs plotted using
Microsoft excel. The results were statistically compared with fresh
media (as a negative control) and also with each group and were
considered as statistically significant if p#0.05.
Results
After IRB approval and informed consent, 22 samples of fresh
lacrimal gland tissue were harvested from exenterated specimens
for orbital malignancies. After histological confirmation of normal
lacrimal gland and exclusion of any underlying pathology, 18 were
included for the study. Cultures were established in 14 of the 18
samples while 4 samples were used for FACS analysis after
enzymatic digestion.
Establishment of human lacrimal gland primary culture
The enzymatic digestion of the freshly harvested lacrimal gland
tissue yielded a heterogeneous population of cells comprising of
clumps of epithelial cells, fibroblasts, single cells of larger size and
some red blood cells (Figure 1a).
On initially plating the isolated cells on uncoated tissue culture
dishes, the fibroblasts settled down and adhered within 2 hours at
the end of this time period, the floating cells were aspirated and
seeded on dishes coated with Matrigel
TM, collagen I or on
denuded HAM.
The epithelial cells from the suspension adhered to Matrigel
TM,
collagen I coated dishes and denuded HAM with initiation of cell
proliferation within 1–3 days (Figure 1b). Preferential adhesion of
the cell clumps, optimal proliferation and morphology of the
epithelial cells was seen on Matrigel
TM. Within 15–20 days, the
epithelial islands expanded to form a monolayer in all the three
substrates (Figure 1c). The cells showed thin cytoplasmic borders,
Table 3. List of antibodies and dilutions used for flow
cytometry.
S. No. Antibody Dilution Company
1 ABCG2 1:100 BD Biosciences
2. c-kit 1:100 Millipore
3. E-cadherin 1:100 Millipore
4. CD90 1:200 eBiosciences
5. EpCAM 1:100 BD Biosciences
6. CD133 1:20 Miltenyi Biotech
doi:10.1371/journal.pone.0029458.t003
Table 4. List of secondary antibodies and dilutions.
S. No. Antibody Dilution Company
1. Alexa Fluor 488 1:200 Invitrogen
2. PE 1:200 eBiosciences
3. FITC 1:200 Invitrogen
doi:10.1371/journal.pone.0029458.t004
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(Figure 1d). The cultures on Matrigel showed sustained epithelial
morphology for 30–35 days. (Panel showing day 14 epithelial cell
growth on uncoated dishes, denuded HAM, collagen 1 and
Matrigel
TM coated dishes is included as Figure S1).
In addition, there wasformation of ‘spherules’ (Figure 1e,f) in
all matrices by day 16–18. The cultures also showed develop-
ment of cord-like cellular structures between two spherules
suggesting an attempt towards formation of duct-like structures
(Figure 1g–i).
Table 5. Primer sequences used for RT-PCR.
S. No. Name Sequence Product Size (bp)
1. Lactoferrin - Forward CAGACCGCAGACATGAAACT 479
Lactoferrin- Reverse TTCAAGAATGGACGAAGTGT
2. Lysozyme - Forward CTCTCATTGTTCTGGGGC 350
Lysozyme - Reverse ACGGACAACCCTCTTTGC5
3. scIgA - Forward AATGCTGACCTCCAAGTGCTAAAG 242
scIgA - Reverse ATCACCACACTGAATGAGCCATCC
4. GAPDH - Forward CAGAACATCATCCCTGCATCCACT 250
GAPDH - Reverse GTTGCTGTTGAAGTCACAGGAGAC
doi:10.1371/journal.pone.0029458.t005
Figure 1. Establishment of human lacrimal gland primary cultures. a) Heterogenous cell population isolated after enzymatic digestion of the
lacrimalgland.b)Cellclumpsadheretothesubstrateasdiscreteislandsandshowinitiationofproliferationwithin1–3days.c)Theislands proliferateand
form a confluent monolayer within 15–20 days. d) The cells in the monolayer show thin cytoplasmic border, vesicular nucleus and granularity in the
cytoplasm. e–f) Spherules are formed by day 16–18 (arrow head). g–i) Cord-like connections (arrow head) are seen to develop between the spherules.
doi:10.1371/journal.pone.0029458.g001
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spindle cells that form a confluent monolayer by around 5–7 days.
The cells were spindle shaped, with slight granularity in their
cytoplasm and distinct nucleus (Figure 2a). In addition, the culture
also showed the presence of a third type of cellular morphology:
oval and plump cells that organized themselves in whorls
(Figure 2b). These could be myoepithelial in nature.
A flow cytometric comparison was also made of the heteroge-
neous cell population growing on uncoated, collagen 1 and
Matrigel
TM coated dishes. The day 14 data shows that about
85.164.9% of the cells growing on uncoated tissue culture dishes are
positive for mesenchymal marker CD90 while only 0.6560.35%
were positive for epithelial marker EpCAM; on collagen 1 coated
dishes, 16.760.85% of the cells showed CD 90 positivity while
1.260.3% were EpCAM positive; as for Matrigel, 13.3610.2% of
the cells were mesenchymal (CD90 positive) while 2.261.7% were
epithelial (EpCAM positive) (Table S1).
Immunophenotyping of native and cultured lacrimal
gland cells
Immunohistochemistry. The formalin fixed, paraffin
embedded human lacrimal gland tissues, on hematoxylene and
eosin staining show the typical tissue architecture of human
lacrimal gland (Figure 3a). These paraffin embedded sections
showed immunoreactivity for pan-cytokeratin, lysozyme,
vimentin, c-kit, p63, /-SMA, GFAP and S-100. The staining
pattern reveals localization of pan-cytokeratin (Figure 3b) and
secretory protein lysozyme (Figure 3c) mostly in the acinar cells
with very few ductal cells showing faint positivity. Vimentin
localized in the myoepithelial cells around the acinar cells and in
the fibroblasts of the stroma. Few acinar cells also show vimentin
positivity (Figure 3d). c-kit expression was seen as a membrane
marker in the cell membrane of the acinar cells (Figure 3e) while
p63, GFAP, S-100 and /-SMA (Figure 3f–i) was found in the cells
enveloping the acinar cells (myoepithelial cells).
Immunocytochemistry
The cultures showed a heterogeneous population of cells with
immunoreactivity for epithelial, myoepithelial as well as mesen-
chymal markers. The cells with epithelial morphology show
positivity for CK3/12, p63, E-cadherin and lysozyme. CK3/12
and lysozyme localized in the cytoplasm of the cells, p63 in the
nucleus while E-cadherin was seen to localize around the plasma
membrane and between the epithelial cells. Some of the cells also
showed immunopositivity for ABCG2 (Figure 4).
The spindle shaped cells were positive for mesenchymal markers
CD90 and vimentin. The oval and plump cells were immunore-
active for GFAP and S-100 protein, which may be indicative of
their myoepithelial/ductal origin (Figure 4).
Flow Cytometry
The FACS analysis of freshly isolated cells from the human
gland showed that 14.863.45% of the cells were positive for
epithelial marker EpCAM, 2.960.91% for mesenchymal marker
CD90 and 3.760.33% positive for E-cadherin indicative of
epithelial/epithelial progenitor nature. Cells in this heterogeneous
mix also showed immunoreactivity towards stem cell markers like
ABCG2 (3.160.61%) and c-kit (6.762.0%). CD133 positivity was
seen in 0.360.1% of the cells (Table 6) (Figure 5i).
FACS analysis of cultured lacrimal gland cells also showed the
presence of stem cells as well as differentiated cells in day 14–18
cultures. 2.261.7%of the cells were positive for EpCAM,
13.3610.2% positive for CD 90. The cultures had a population
of cells with positivity for stem cell markers accounting for
0.3060.15% as ABCG2 positive and 0.2060.05% as c-kit positive.
Figure 2. Other cell types in culture. a) Spindle shaped cells with slight granularity in their cytoplasm and distinct nucleus, are seen on uncoated
culture dishes and these attain confluence within 5–7 days. b) Oval and plump cells that organize themselves in whorls are also seen. These may be
myoepithelial in nature.
doi:10.1371/journal.pone.0029458.g002
Figure 3. Immunohistochemistry on normal human lacrimal
gland. H&E staining shows the normal histology of the lacrimal gland.
Marker staining pattern shows localization of pan-cytokeratin (AE1/AE3)
and lysozyme (Lzy) in the cytoplasm of the acinar cells while c-kit is seen
in the plasma membrane of acinar cells. p63, glial fibrillary acidic protein
(GFAP), S-100 protein and /-SMA localize in the myoepithelial cells
enveloping the acinar cells. Vimentin is seen in the myoepithelial cells
and also in some of the acinar cells. All images are at 406magnification
except H&E which is at 106.
doi:10.1371/journal.pone.0029458.g003
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day 21–25 of in-vitro culture the number of cells expressing the stem
cell markers ABCG2 and c-kit had reduced to 0.260.13% and
0.1360.03% respectively while the expression of differentiated markers
like CD90 had increased to 30.2563.35%. This could possibly be and
indication of the ongoing differentiation under in-vitro conditions
(Table 6) (FACS plots not included for day 21–25).
ALDEFLUOR Assay
In the freshly isolated cells, 2.4% to 6.3% showed high ALDH1
activity (mean: 3.861.26%). Co-expression of high ALDH1 and
ABCG2 was seen in 0.1360.04%, and high ALDH1 and c- kit in
0.21%60.02% of the cells (Table 7) (Figure 6i).
The day 14–18 cultured lacrimal gland cells also showed a
population with high ALDH activity accounting for 2.761.5% of
the total population acquired (Figure 6ii) which decreases to
1.160.5% by day 21. Co-expression of high ALDH1 with
ABCG2/c-kit positivity was not evaluated in the cultured cells
since their level of expression in the native tissue itself was low to
begin with. (FACS plots not included for day 21–25).
C. Secretome Assessment
Reverse- Transcriptase Polymerase Chain Reaction. In
order to confirm the presence of mRNA for the secretory proteins,
lactoferrin, lysozyme and scIgA, in the cultured human lacrimal
gland cells RT PCR was performed with specific primers. The
cDNA synthesized by reverse transcription showed the expression
of scIgA, lactoferrin and lysozyme (Figure 7) in the cells thereby
confirming that the cultured cells retained their physiological
ability to synthesize the secretory proteins.
Enzyme Linked Immunosorbent Assay
The conditioned media of day 6–7 human lacrimal gland
cultures showed the presence of scIgA, lactoferrin and lysozyme
Figure 4. Immunocytochemistry on in-vitro cultured human lacrimal gland cells. Cells with epithelial morphology stain positively with E-
cadherin, CK3/12, lysozyme and p63; oval and plump cells stain positive for myoepithelial markers GFAP and S100 protein while the spindle shaped
cells are seen to be positive for mesenchymal markers CD90 and vimentin. Some cells also show immunopositivity for ABCG2. Secondary antibody
uses is fluoresceine isothiocyanate (green) and the counter-stain is propidium iodide (red).
doi:10.1371/journal.pone.0029458.g004
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the conditioned media by the cells growing on each of the matrices
was calculated using the standard calibration curves (Figure 8a–c).
The protein secretion was further augmented by treatment with
100 mM of carbachol for 30 min (Figure 8d–f). The main effect of
carbachol stimulation was statistically significant for sc IgA (F(1,
8)=15.07; p,0.01), lysozyme (F(1,8)=5.86; p=0.02) and lacto-
ferrin (F(1,8)=11.44; p,0.01) secretion.
The amount of protein secreted by the cells post carbachol
stimulation on each of the three matrices is tabulated in Table 8.
The cells cultured on Matrigel showed slightly higher levels of
secretory proteins in the conditioned media (Figure 8d–f).
However, the main effect of matrices and the interaction between
matrices and carbachol stimulation was not statistically significant
for scIgA (F (2,8)=1.33; p=0.27) and lactoferrin (F(2,8)=0.86;
p=0.43) secretion; but showed significance for lysozyme secretion
(F(2,8)=5.0; p=0.01).
The trend in protein secretion by the cultured cells at day 7, day
14 and day 21 was also evaluated. The results indicate that in-vitro
tear protein secretion tends to increase from day 7 to day 14 and
then declines by day 21. (Table S2).
This change over a time period from day 7 to day 21 was
statistically analysed and found to be significant: scIgA (F(1,6)=
21.92; p,0.01); lysozyme (F(1,6)=7.45; p,0.01) and lactoferrin
(F(1,6)=21.3; p,0.01).
Discussion
Similar to the role of other exocrine glands of the body, the
lacrimal gland plays a major role in lubricating the ocular surface
epithelium. The susceptibility of the gland to immune mediated
insults, radiation induced damage and age related atrophic
changes, which cannot be satisfactorily managed with the current
line of therapeutics, causes high incidences of morbidity in the
population and raises a need for replacement therapy with
functionally competent cells.
The two important steps towards cell therapy would include
establishment of functionally competent lacrimal gland cultures
Figure 5. Flow Cytometry Data. i) Flow cytometric profile of freshly isolated (FI) cells. ii) Flow cytometric profile of cells 14–18 days post in-vitro
culture.
doi:10.1371/journal.pone.0029458.g005
Table 6. Flow cytometry data: Percentage of various marker in freshly isolated, day 14–18 and day 21–25 of in-vitro culture of
human lacrimal gland.
S. No. Marker
% Expressed at t=0
(Mean± SEM)
% Expressed at day 14 of in-vitro culture
(Mean± SEM)
% Expressed at day 21 of in-vitro
culture (Mean± SEM)
1. ABCG2 3.160.61 0.360.15 0.260.13
2. c-kit 6.762.0 0.260.05 0.1360.03
3. E-cadherin 3.760.33 0.660.4 0.4560.25
4. EpCAM 14.863.45 2.261.70 0.360.1
5. CD90 2.960.91 13.3610.20 30.2563.35
6. CD133 0.3060.10 0.3060.10 0.2560.05
doi:10.1371/journal.pone.0029458.t006
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existence of stem cells in the native tissue, which can be recruited
to salvage the function of the damaged gland. The present study
provides evidence for both. Our results show that the human
lacrimal gland cells can be cultured in-vitro with retained secretory
function (Figure 1, Figure 7 and Figure 8). In addition to the mere
presence of differentiated cells (epithelial, myoepithelial and
stromal), we also show the formation of ‘spherules’ with attempted
duct-like connections (Figure 1 e–i) and the presence of cells with
stem cell-like phenotype (ABCG2 & ALDH1 high cells) (Figure 5
and Figure 6) under our culture conditions.
While lacrimal gland cultures from rabbit [13], mice [14] and
rat [12] sources are well established, similar evidence from humans
is limited [16]. To the best of our knowledge, this study documents
the first successful method of isolating and culturing functionally
competent fresh human lacrimal gland cells using an enzyme
cocktail of collagenase and hyaluronidase. The established cultures
can be maintained in-vitro for 30–35 days. This method not only
gives an adequate yield of differentiated cells, but also provides
early evidence for the presence of putative stem cells in the tissues
as suggested by the expression of stem cell makers ABCG2
(3.160.61%) and high ALDH1 (3.8%61.26%).
The influence of culture condition on cell proliferation and
maintenance of function, especially in the case of lacrimal gland
cultures, has been well documented [29,30,31]. It is important that
the right combination of substrate, media and growth factors be
Figure 6. Aldefluor Assay. i) Flow cytometric data showing ALDH1 high cells in the freshly isolated (FI) cell population. ii) Flow cytometric data
showing ALDH1 high cells in day 14–18 in-vitro cultures.
doi:10.1371/journal.pone.0029458.g006
Table 7. ALDEFLUOR Assay.
S. No. Marker % Expressed at t=0 (Mean± SEM) % Expressed at day 14 of in-vitro culture (Mean± SEM)
1. ALDH1 high 3.861.26 2.761.54
2. ALDH high + c-kit 0.260.02 -
3. ALDH high + ABCG2 0.160.04 -
doi:10.1371/journal.pone.0029458.t007
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gland cultures have been established on collagen [30], Matrigel
TM
[12,15], HAM [32] and on artificial matrices like polyethersulfone
[33]. Our study with human tissues also suggest that a com-
bination of Matrigel
TM/HAM/collagen as substrate and EGF
supplemented HepatoSTIM
TM media optimally supports the
growth of different sub-populations of cells and helps them retain
their characteristic marker expression (E-cadherin, CD90, S100,
GFAP) as well as optimal secretory function (scIgA, lactoferrin and
lysozyme secretion). However, morphological evidence and rate of
cell proliferation seems to favor Matrigel
TM as substrate even
though this difference is not statistically significant. Another
interesting feature noted in this study is morphologic evidence
towards formation of spherules and ductioles. The formation of
spheres has been reported in salivary gland cultures (salispheres)
[34], prostate cultures (prostaspheres) [35] and a single study on
spheroidal aggregation of rabbit lacrimal gland cells grown in
microgravity environment of a rotary cell culture system [36]. The
salispheres have been shown to have stem cells and these when
transplanted into animal models of radiation-induced xerostomia
could rescue the function of the gland [34]. Similarly, the
prostaspheres on combined transplantation with embryonic day
17 urogenital sinus (which provides the mesenchymal niche) into
nude mice could give rise to tissues with glandular prostate
morphology [35]. We believe that the spheres formed under our
culture conditions could be similar to the salispheres and
prostaspheres in their cellular organization and further investiga-
tions in this are ongoing.
In order to fulfill the long-term goal of using the in-vitro
expanded lacrimal cultures for rescue of function of damaged
gland it is important that the secretory profile of these cells be
evaluated. Yoshino et.al. [16] reported a study on human lacrimal
gland using cadaveric tissue; however, the report does not
document the complete secretory profile of the cultured cells. In
contrast, the present study shows that in-vitro cultures of human
Figure 7. RT-PCR showing appropriate product bands for
scIgA, lactoferrin and lysozyme in day 14 in-vitro cultures on all
HAM (H), collagen I (C) and Matrigel
TM(M). Negative (N) panel
shows no amplification product.
doi:10.1371/journal.pone.0029458.g007
Figure 8. Secretome Assessment by ELISA. a–c): Standard calibration curve for lysozyme, scIgA and lactoferrin. d–f): Plot of mean optical density
values for secreted proteins lysozyme, scIgA and lactoferrin on HAM, collagen and Matrigel
TM pre and post carbachol stimulation.
doi:10.1371/journal.pone.0029458.g008
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secreting major tear proteins like lysozyme, scIgA and lactoferrin
(Figure 7 and 8). This secretory profile has also been quantified by
sandwich ELISA technique using the calibration curve generated
for each of the three proteins. The calibration curve was generated
in two sets of experiments in which readings were taken in
triplicates and since the optical density values for the remaining
three sets were very similar, the same calibration curve was used to
estimate the protein quantity. Our results show that the secretion
of these proteins ranges from 3.86 to 71.4 ng/ml of scIgA, 5.78 to
33.94 ng/ml of lysozyme and 44.5 to 45.65 ng/ml of lactoferrin
on HAM, to 1.41 to 27.58 ng/ml of scIgA, 0.21 to 18.34 ng/ml of
lysozyme and 28.52 to 30.41 ng/ml of lactoferrin on collagen I
coated dishes to 47.43 to 61.56 ng/ml of scIgA, 24.36 to
144.74 ng/ml of lysozyme and 32.45 to 40.31 ng/ml of lactoferrin
on Matrigel
TM coated dishes (Table 8) in day 7 cultures. These
cultures retain their secretory ability even till day 21. As
anticipated, the amount of protein secretion tends to increase
from day 7 to day 14 of in-vitro culture and then declines by day 21
(Table S2). The possible reason for this could be that by day 14 the
cultures tend to attain confluence and so there are more number of
acinar cells secreting the proteins; however post confluence the
cells tend to reduce the amount of protein secretion either because
on passaging these cells they acquire a more fibroblastic
morphology or if they are left unpassaged they stop proliferating
and hence protein synthesis also reduces. However, it was noted
that the level of proteins secreted by cultures growing on Matrigel
remains the highest in all the three cases. An interesting
observation made here is that the in-vitro pattern of secretion of
these proteins is the same as that seen in-vivo i.e. Lysozyme.scI-
gA.Lactoferrin [37].We do observe a wide range in the quantity
of proteins secreted in-vitro. One of the possible reasons for this
could be the experimental variables like the age of donor tissue. In
the present study, tissue was harvested from exenterated specimens
of patients with an age range of 3 years to 65 years. Since the
lacrimal protein secretions tend to reduce with increasing age we
feel this could be an important factor contributing to such a wide
range in quantity of protein secreted in-vitro.
Both lacrimal and salivary gland acinar cells share similar
developmental, morphologic and functional characteristics and
show similar reduction in function when injured [38,39,40] but
unlike the salivary gland where there is evidence of stem/
progenitor cell compartment in the terminal ductioles [17], such
evidence is restricted to one preliminary report of stem cells in the
mouse lacrimal gland which can be recruited to repair damage to
the gland and which can subsequently be cultured in-vitro [24].
Our results give preliminary evidence indicating that the stem-like
cells are present in the lacrimal gland but their exact locations is
still under investigation. The expression of these stem-like cells in
the native tissue could range between 3.160.61% (ABCG2
expression) to 3.8%61.26% (high ALDH1 expression) and
between 0.360.15% (ABCG2 expression) to 2.761.54% (ALDH1
high expression) after 14–18 days of in-vitro culture. It is
noteworthy that our culture system could maintain stem cells in-
vitro even by day 21 though their numbers reduced to 0.260.13%
(ABCG2) to 1.160.5% (ALDH1 high expression). The results of
the immunohistochemistry experiments indicate that acinar cells
which show strong positivity for vimentin could be the stem cells.
However, for the lack of substantiating data, at the present time,
no concrete inference can be drawn.
In order to substantiate the evidence of stem-like/progenitor
cells in our culture system, clonal or similar stem cell assays have to
be performed either with freshly isolated cells or cells obtained
after sorting for the stem cell markers. While animal studies and
clone forming ability would have added value to this study, the
formation of spherules with ‘duct-like’ structures between them are
important novel findings, which leads us to believe that we may be
able to simulate an in-vivo mimicry under our culture conditions.
Even though dry eye syndrome has a global prevalence the
treatment still remains palliative and conservative, with artificial
tear substitutes and lubricants forming the main stay of clinical
management. A similar spectrum of signs and symptoms exist in the
case of dry mouth syndrome (xerostomia) caused due to damage to
the salivary gland. This damage, similar to lacrimal gland, can be
due to aging, hormonal imbalance or radiotherapy induced. The
management strategy in such cases used to be palliative but recent
reports in literature show the reversal of radiation-induced
xerostomia with cell therapy in animal models [34]. The success
obtained in these animal models of xerostomia has now shifted the
focustowardsexploringsimilaroptions,especiallyinconditionswith
irreparable damage to the lacrimal gland tissue.
In summary, this study provides the first evidence for the
successful growth of fresh human lacrimal gland tissues in-vitro with
an attempt towards duct-like formation and retained secretory
function. The study also gives the first preliminary evidence for the
presence of stem-like cells in the native human lacrimal gland
tissue and these can be maintained under in-vitro condition.
Further validation of this data would allow the development of a
functionally competent 3 D construct for potential clinical
application in severe cases of radiation induced dry eye.
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Table 8. ELISA data: Secretion of tear proteins on various
matrices post carbachol stimulation on day 6–7.
Tear Protein HAM (ng/ml) Collagen I (ng/ml) Matrigel
TM (ng/ml)
Lysozyme 5.78 to 33.94 0.21 to 18.34 24.36 to 144.74
Sc IgA 3.86 to 71.40 1.41 to 27.58 47.43 to 61.56
Lactoferrin 44.50 to 45.65 28.52 to 30.41 32.45 to 40.31
doi:10.1371/journal.pone.0029458.t008
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